{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "27",
                "@timestamp": "2023-07-27T13:14:06.000006-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "07"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Chulalongkorn University",
                "xocs:funding-agency-acronym": "CU",
                "xocs:funding-agency": "Chulalongkorn University",
                "xocs:funding-id": "RCU_H_64_016_30",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
            },
            "xocs:funding-addon-generated-timestamp": "2023-05-13T09:07:24.990Z",
            "xocs:funding-text": "This work was supported by the Ratchadapisek Research Funds, Chulalongkorn University (Grant # RCU_H_64_016_30).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Neurosurgical Unit"},
                                {"$": "Department of Surgery"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125771204"
                                },
                                {"@afid": "60015887"},
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947432937-b995f7c143e7bfe33977066d2b426bcc-1",
                            "ce:source-text": "Neurosurgical Unit, Department of Surgery, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125771204"
                        },
                        "author": [
                            {
                                "ce:given-name": "Atthaporn",
                                "preferred-name": {
                                    "ce:given-name": "Atthaporn",
                                    "ce:initials": "A.",
                                    "ce:surname": "Boongird",
                                    "ce:indexed-name": "Boongird A."
                                },
                                "@author-instance-id": "OB2BibRecID-947432937-f8cc5d0d4f3801936d3ec39b3ec94c40-1",
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Boongird",
                                "@auid": "16041254300",
                                "ce:indexed-name": "Boongird A."
                            },
                            {
                                "ce:given-name": "Nopphon",
                                "preferred-name": {
                                    "ce:given-name": "Nopphon",
                                    "ce:initials": "N.",
                                    "ce:surname": "Lekcharoensombat",
                                    "ce:indexed-name": "Lekcharoensombat N."
                                },
                                "@author-instance-id": "OB2BibRecID-947432937-aaf3deee483e86c61f2f77e8358eeda9-1",
                                "@seq": "2",
                                "ce:initials": "N.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Lekcharoensombat",
                                "@auid": "58180412400",
                                "ce:indexed-name": "Lekcharoensombat N."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pathology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125769074"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947432937-203bd2985c6787136e340044f7de4fe0-1",
                            "ce:source-text": "Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125769074"
                        },
                        "author": [{
                            "ce:given-name": "Artit",
                            "preferred-name": {
                                "ce:given-name": "Artit",
                                "ce:initials": "A.",
                                "ce:surname": "Jinawath",
                                "ce:indexed-name": "Jinawath A."
                            },
                            "@author-instance-id": "OB2BibRecID-947432937-e5b83db60e1816de8f7357b2ec4b1368-1",
                            "@seq": "3",
                            "ce:initials": "A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Jinawath",
                            "@auid": "8623186500",
                            "ce:indexed-name": "Jinawath A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Pathology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "107900103"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947432937-0b020f607676dd16a17f1e73a1a375fc-1",
                            "ce:source-text": "Department of Pathology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "107900103"
                        },
                        "author": [
                            {
                                "ce:given-name": "Talent",
                                "preferred-name": {
                                    "ce:given-name": "Talent",
                                    "ce:initials": "T.",
                                    "ce:surname": "Theparee",
                                    "ce:indexed-name": "Theparee T."
                                },
                                "@author-instance-id": "OB2BibRecID-947432937-46e219ced7c7b68588ff9246101329c8-1",
                                "@seq": "4",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Theparee",
                                "@auid": "56545822500",
                                "ce:indexed-name": "Theparee T."
                            },
                            {
                                "ce:given-name": "Shanop",
                                "preferred-name": {
                                    "ce:given-name": "Shanop",
                                    "ce:initials": "S.",
                                    "ce:surname": "Shuangshoti",
                                    "ce:indexed-name": "Shuangshoti S."
                                },
                                "@author-instance-id": "OB2BibRecID-947432937-74fcde8601f5d81632f70f70492f8f32-1",
                                "@seq": "6",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Shuangshoti",
                                "@auid": "55063064300",
                                "ce:indexed-name": "Shuangshoti S."
                            },
                            {
                                "ce:given-name": "Paul Scott",
                                "preferred-name": {
                                    "ce:given-name": "Paul Scott",
                                    "ce:initials": "P.S.",
                                    "ce:surname": "Thorner",
                                    "ce:indexed-name": "Thorner P.S."
                                },
                                "@author-instance-id": "OB2BibRecID-947432937-a5ef5448a25a113b6b5e16d2620263e3-1",
                                "@seq": "7",
                                "ce:initials": "P.S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Thorner",
                                "@auid": "7005811935",
                                "@orcid": "0000-0001-6571-5566",
                                "ce:indexed-name": "Thorner P.S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Academic Affairs"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "128315048"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947432937-e7325bf6fe264a93ef91dfe34a35b6f8-1",
                            "ce:source-text": "Academic Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "128315048"
                        },
                        "author": [{
                            "ce:given-name": "Talent",
                            "preferred-name": {
                                "ce:given-name": "Talent",
                                "ce:initials": "T.",
                                "ce:surname": "Theparee",
                                "ce:indexed-name": "Theparee T."
                            },
                            "@author-instance-id": "OB2BibRecID-947432937-46e219ced7c7b68588ff9246101329c8-1",
                            "@seq": "4",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Theparee",
                            "@auid": "56545822500",
                            "ce:indexed-name": "Theparee T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Radiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60002620",
                                    "@dptid": "103183428"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947432937-1798e533299b1b2be1dc0750565ed15f-1",
                            "ce:source-text": "Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "103183428"
                        },
                        "author": [{
                            "ce:given-name": "Nutchawan",
                            "preferred-name": {
                                "ce:given-name": "Nutchawan",
                                "ce:initials": "N.",
                                "ce:surname": "Jittapiromsak",
                                "ce:indexed-name": "Jittapiromsak N."
                            },
                            "@author-instance-id": "OB2BibRecID-947432937-a9cd04412577eb491fbd56a8c2a84181-1",
                            "@seq": "5",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Jittapiromsak",
                            "@auid": "57190178086",
                            "ce:indexed-name": "Jittapiromsak N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60002620",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Chulalongkorn GenePRO Center"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60002620"},
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-947432937-99868ed3c56370fceea80f39e4c179d4-1",
                            "ce:source-text": "Chulalongkorn GenePRO Center, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"
                        },
                        "author": [
                            {
                                "ce:given-name": "Shanop",
                                "preferred-name": {
                                    "ce:given-name": "Shanop",
                                    "ce:initials": "S.",
                                    "ce:surname": "Shuangshoti",
                                    "ce:indexed-name": "Shuangshoti S."
                                },
                                "@author-instance-id": "OB2BibRecID-947432937-74fcde8601f5d81632f70f70492f8f32-1",
                                "@seq": "6",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Shuangshoti",
                                "@auid": "55063064300",
                                "ce:indexed-name": "Shuangshoti S."
                            },
                            {
                                "ce:given-name": "Chinachote",
                                "preferred-name": {
                                    "ce:given-name": "Chinachote",
                                    "ce:initials": "C.",
                                    "ce:surname": "Teerapakpinyo",
                                    "ce:indexed-name": "Teerapakpinyo C."
                                },
                                "@author-instance-id": "OB2BibRecID-947432937-ffaf026df9df16b10e3ab4c240fa5155-1",
                                "@seq": "8",
                                "ce:initials": "C.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Teerapakpinyo",
                                "@auid": "56653456600",
                                "ce:indexed-name": "Teerapakpinyo C."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60016849",
                            "@country": "can",
                            "city": "Toronto",
                            "organization": [
                                {"$": "Department of Laboratory Medicine and Pathobiology"},
                                {"$": "University of Toronto"}
                            ],
                            "affiliation-id": {
                                "@afid": "60016849",
                                "@dptid": "113804453"
                            },
                            "state": "ON",
                            "@affiliation-instance-id": "OB2BibRecID-947432937-e5d8d36b15816956ddcf418aceec0f20-1",
                            "ce:source-text": "Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada",
                            "@dptid": "113804453"
                        },
                        "author": [{
                            "ce:given-name": "Paul Scott",
                            "preferred-name": {
                                "ce:given-name": "Paul Scott",
                                "ce:initials": "P.S.",
                                "ce:surname": "Thorner",
                                "ce:indexed-name": "Thorner P.S."
                            },
                            "@author-instance-id": "OB2BibRecID-947432937-78e433782b3b02091f255b9cad07cbe1-1",
                            "@seq": "7",
                            "ce:initials": "P.S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Thorner",
                            "@auid": "7005811935",
                            "ce:indexed-name": "Thorner P.S."
                        }]
                    }
                ],
                "citation-title": "Glioblastoma with novel EGFR mutations (T790M and exon 20 insertion) yet unresponsive to osimertinib: A case report",
                "abstracts": "Â© 2023 Wiley Periodicals LLC.Glioblastoma (GBM) is a high-grade adult-type IDH-wildtype diffuse glioma, commonly harboring epidermal growth factor receptor (EGFR) amplification. Here, we describe a case of a 49-year-old man with a GBM harboring a TERT promoter mutation. Despite surgical and chemoradiation therapy, the tumor recurred. At that time, comprehensive genomic profiling by next-generation sequencing identified two rare mutations in EGFR: T790M and an exon 20 insertion. Based on these findings, the patient elected to undergo off-label therapy with osimertinib, a third-generation EGFR tyrosine kinase inhibitor that has shown promising results in non-small cell lung carcinoma, including metastatic to brain, with exactly the same EGFR mutations. Moreover, the drug has excellent central nervous system penetration. Even so, no clinical response was observed, and the patient succumbed to the disease. The lack of response may be related to the specific nature of the EGFR mutations, and/or other unfavorable tumor biology overriding any benefit from osimertinib.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Chulalongkorn GenePRO Center"},
                            {"$": "Research Affairs"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "@affiliation-instance-id": "OB2BibRecID-947432937-6f0312f197561956f12e8cf9e3465ab5-1",
                        "ce:source-text": "Chulalongkorn GenePRO Center, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:given-name": "Chinachote",
                        "@author-instance-id": "OB2BibRecID-947432937-3282c264bf7dfbb0bca84c5ab7a4648b-1",
                        "ce:initials": "C.",
                        "ce:surname": "Teerapakpinyo",
                        "ce:indexed-name": "Teerapakpinyo C."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "comprehensive genomic profiling",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "EGFR",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "exon 20 insertion",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "glioblastoma",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "next-generation sequencing",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "osimertinib",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "T790M",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "tyrosine kinase inhibitor",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2264",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Genes Chromosomes and Cancer",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "62",
                            "@issue": "7"
                        },
                        "pagerange": {
                            "@first": "423",
                            "@last": "429"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Genes Chromosomes and Cancer",
                    "publicationdate": {
                        "month": "07",
                        "year": "2023",
                        "date-text": "July 2023",
                        "day": "01"
                    },
                    "codencode": "GCCAE",
                    "sourcetitle-abbrev": "Genes Chromosomes Cancer",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "10982264",
                            "@type": "electronic"
                        },
                        {
                            "$": "10452257",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "John Wiley and Sons Inc"},
                    "@srcid": "22139"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "14",
                                    "classification-description": "Radiology"
                                },
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "8",
                                    "classification-description": "Neurology and Neurosurgery"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "1311"},
                                {"$": "1306"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "BIOC"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "79079-06-4",
                                    "chemical-name": "epidermal growth factor receptor"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "1421373-65-0"},
                                        {"$": "1421373-66-1"}
                                    ],
                                    "chemical-name": "osimertinib"
                                },
                                {
                                    "cas-registry-number": "85622-93-1",
                                    "chemical-name": "temozolomide"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "EGFR protein, human"},
                                {"chemical-name": "ErbB Receptors"},
                                {"chemical-name": "osimertinib"},
                                {"chemical-name": "Protein Kinase Inhibitors"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "This work was supported by the Ratchadapisek Research Funds, Chulalongkorn University (Grant # RCU_H_64_016_30).",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "25",
                    "@timestamp": "BST 07:08:11",
                    "@year": "2023",
                    "@month": "07"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2022465472",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "640917530",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "947432937",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230324877",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "36994936",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20230991274",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20231349580",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20239009345875",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85152274374",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85152274374",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "640917530",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76771699",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1002/gcc.23143"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "45",
                "reference": [
                    {
                        "ref-fulltext": "Dalton WB, Forde PM, Kang H, et al. Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins molecular tumor board. JCO Precis Oncol. 2017;2017:PO.16.00046.",
                        "@reference-instance-id": "OB2BibRecID-947432937-0af948ab9571c65b43022f24d133ed73-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins molecular tumor board"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0001",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85046893353",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "2017"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Dalton",
                                        "ce:indexed-name": "Dalton W.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Forde",
                                        "ce:indexed-name": "Forde P.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Kang",
                                        "ce:indexed-name": "Kang H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JCO Precis Oncol"
                        },
                        "ce:source-text": "Dalton WB, Forde PM, Kang H, et al. Personalized medicine in the oncology clinic: implementation and outcomes of the Johns Hopkins molecular tumor board. JCO Precis Oncol. 2017;2017:PO.16.00046."
                    },
                    {
                        "ref-fulltext": "Haendel M, Chute C, Robinson P. Classification, ontology, and precision medicine. N Engl J Med. 2018;379:1452-1462.",
                        "@reference-instance-id": "OB2BibRecID-947432937-71611366313ff041e8608da0a2d58895-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Classification, ontology, and precision medicine"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0002",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054779148",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "379"},
                                "pagerange": {
                                    "@first": "1452",
                                    "@last": "1462"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Haendel",
                                    "ce:indexed-name": "Haendel M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Chute",
                                    "ce:indexed-name": "Chute C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Robinson",
                                    "ce:indexed-name": "Robinson P."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Haendel M, Chute C, Robinson P. Classification, ontology, and precision medicine. N Engl J Med. 2018;379:1452-1462."
                    },
                    {
                        "ref-fulltext": "Kondo T, Matsubara J, Quy PN, et al. Comprehensive genomic profiling for patients with chemotherapy-naive advanced cancer. Cancer Sci. 2021;112(1):296-304.",
                        "@reference-instance-id": "OB2BibRecID-947432937-fec2136bfc37313d521352f9e5aabb83-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Comprehensive genomic profiling for patients with chemotherapy-naive advanced cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0003",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85096665338",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "112",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "296",
                                    "@last": "304"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kondo",
                                        "ce:indexed-name": "Kondo T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Matsubara",
                                        "ce:indexed-name": "Matsubara J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Quy",
                                        "ce:indexed-name": "Quy P.N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Sci"
                        },
                        "ce:source-text": "Kondo T, Matsubara J, Quy PN, et al. Comprehensive genomic profiling for patients with chemotherapy-naive advanced cancer. Cancer Sci. 2021;112(1):296-304."
                    },
                    {
                        "ref-fulltext": "Le Tourneau C, Delord JP, Goncalves A, et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol. 2015;16(13):1324-1334.",
                        "@reference-instance-id": "OB2BibRecID-947432937-f05f46eb68b2ef05a78903a423d410bd-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0004",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84954026435",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "13"
                                },
                                "pagerange": {
                                    "@first": "1324",
                                    "@last": "1334"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Le Tourneau",
                                        "ce:indexed-name": "Le Tourneau C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Delord",
                                        "ce:indexed-name": "Delord J.P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Goncalves",
                                        "ce:indexed-name": "Goncalves A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Le Tourneau C, Delord JP, Goncalves A, et al. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol. 2015;16(13):1324-1334."
                    },
                    {
                        "ref-fulltext": "Kou T, Kanai M, Yamamoto Y, et al. Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors. Cancer Sci. 2017;108(7):1440-1446.",
                        "@reference-instance-id": "OB2BibRecID-947432937-c7b8b4995675f584bd92d6228c1e1ced-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0005",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85019868410",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "108",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "1440",
                                    "@last": "1446"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kou",
                                        "ce:indexed-name": "Kou T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kanai",
                                        "ce:indexed-name": "Kanai M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Yamamoto",
                                        "ce:indexed-name": "Yamamoto Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Sci"
                        },
                        "ce:source-text": "Kou T, Kanai M, Yamamoto Y, et al. Clinical sequencing using a next-generation sequencing-based multiplex gene assay in patients with advanced solid tumors. Cancer Sci. 2017;108(7):1440-1446."
                    },
                    {
                        "ref-fulltext": "Sunami K, Ichikawa H, Kubo T, et al. Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study. Cancer Sci. 2019;110(4):1480-1490.",
                        "@reference-instance-id": "OB2BibRecID-947432937-7bc04faa08ba4ef89b41f936910e93b9-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0006",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85063807614",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "110",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "1480",
                                    "@last": "1490"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Sunami",
                                        "ce:indexed-name": "Sunami K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Ichikawa",
                                        "ce:indexed-name": "Ichikawa H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Kubo",
                                        "ce:indexed-name": "Kubo T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Sci"
                        },
                        "ce:source-text": "Sunami K, Ichikawa H, Kubo T, et al. Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: a hospital-based study. Cancer Sci. 2019;110(4):1480-1490."
                    },
                    {
                        "ref-fulltext": "Fang W, Huang Y, Hong S, et al. EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer. BMC Cancer. 2019;19(1):595.",
                        "@reference-instance-id": "OB2BibRecID-947432937-ff0e46f016362492de8cf4323e147c92-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0007",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85067468414",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "595"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Fang",
                                        "ce:indexed-name": "Fang W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Hong",
                                        "ce:indexed-name": "Hong S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Cancer"
                        },
                        "ce:source-text": "Fang W, Huang Y, Hong S, et al. EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer. BMC Cancer. 2019;19(1):595."
                    },
                    {
                        "ref-fulltext": "Leonetti A, Sharma S, Minari R, Perego P, Giovannetti E, Tiseo M. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br J Cancer. 2019;121(9):725-737.",
                        "@reference-instance-id": "OB2BibRecID-947432937-f43bdaef74a4af1ae506457ccbc5d11c-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0008",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85074293851",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "121",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "725",
                                    "@last": "737"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Leonetti",
                                    "ce:indexed-name": "Leonetti A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Sharma",
                                    "ce:indexed-name": "Sharma S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Minari",
                                    "ce:indexed-name": "Minari R."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Perego",
                                    "ce:indexed-name": "Perego P."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Giovannetti",
                                    "ce:indexed-name": "Giovannetti E."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Tiseo",
                                    "ce:indexed-name": "Tiseo M."
                                }
                            ]},
                            "ref-sourcetitle": "Br J Cancer"
                        },
                        "ce:source-text": "Leonetti A, Sharma S, Minari R, Perego P, Giovannetti E, Tiseo M. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br J Cancer. 2019;121(9):725-737."
                    },
                    {
                        "ref-fulltext": "Vyse S, Huang PH. Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer. Signal Transduct Target Ther. 2019;4:5.",
                        "@reference-instance-id": "OB2BibRecID-947432937-b181214b1fe0444a498475885e5caecc-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0009",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062627578",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {"@first": "5"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Vyse",
                                    "ce:indexed-name": "Vyse S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang P.H."
                                }
                            ]},
                            "ref-sourcetitle": "Signal Transduct Target Ther"
                        },
                        "ce:source-text": "Vyse S, Huang PH. Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer. Signal Transduct Target Ther. 2019;4:5."
                    },
                    {
                        "ref-fulltext": "Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231-1251.",
                        "@reference-instance-id": "OB2BibRecID-947432937-c56e9b7c5514c24fc01f1b9153eabfc4-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "The 2021 WHO classification of tumors of the central nervous system: a summary"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0010",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85111606590",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "8"
                                },
                                "pagerange": {
                                    "@first": "1231",
                                    "@last": "1251"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Louis",
                                        "ce:indexed-name": "Louis D.N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Perry",
                                        "ce:indexed-name": "Perry A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Wesseling",
                                        "ce:indexed-name": "Wesseling P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Neuro Oncol"
                        },
                        "ce:source-text": "Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol. 2021;23(8):1231-1251."
                    },
                    {
                        "ref-fulltext": "Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017;19(suppl_5):v1-v88.",
                        "@reference-instance-id": "OB2BibRecID-947432937-b20be2097d437366339ea579f5ec919b-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0011",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055900939",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "v1",
                                    "@last": "v88"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Q.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Ostrom",
                                        "ce:indexed-name": "Ostrom Q.T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Gittleman",
                                        "ce:indexed-name": "Gittleman H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Liao",
                                        "ce:indexed-name": "Liao P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Neuro Oncol"
                        },
                        "ce:source-text": "Ostrom QT, Gittleman H, Liao P, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014. Neuro Oncol. 2017;19(suppl_5):v1-v88."
                    },
                    {
                        "ref-fulltext": "Weller M, van den Bent M, Preusser M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2020;18(3):170-186.",
                        "@reference-instance-id": "OB2BibRecID-947432937-a2a3c1b9290b4c5bb2cf421c4eb51bec-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0012",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85097426791",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "170",
                                    "@last": "186"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Weller",
                                        "ce:indexed-name": "Weller M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "van den Bent",
                                        "ce:indexed-name": "van den Bent M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Preusser",
                                        "ce:indexed-name": "Preusser M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Rev Clin Oncol"
                        },
                        "ce:source-text": "Weller M, van den Bent M, Preusser M, et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2020;18(3):170-186."
                    },
                    {
                        "ref-fulltext": "An Z, Aksoy O, Zheng T, Fan QW, Weiss WA. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene. 2018;37(12):1561-1575.",
                        "@reference-instance-id": "OB2BibRecID-947432937-b379971fe9079257c36c3e7ad04b7064-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0013",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040327985",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "37",
                                    "@issue": "12"
                                },
                                "pagerange": {
                                    "@first": "1561",
                                    "@last": "1575"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "Z.",
                                    "@_fa": "true",
                                    "ce:surname": "An",
                                    "ce:indexed-name": "An Z."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "O.",
                                    "@_fa": "true",
                                    "ce:surname": "Aksoy",
                                    "ce:indexed-name": "Aksoy O."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Zheng",
                                    "ce:indexed-name": "Zheng T."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Q.W.",
                                    "@_fa": "true",
                                    "ce:surname": "Fan",
                                    "ce:indexed-name": "Fan Q.W."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "W.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Weiss",
                                    "ce:indexed-name": "Weiss W.A."
                                }
                            ]},
                            "ref-sourcetitle": "Oncogene"
                        },
                        "ce:source-text": "An Z, Aksoy O, Zheng T, Fan QW, Weiss WA. Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene. 2018;37(12):1561-1575."
                    },
                    {
                        "ref-fulltext": "Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462-477.",
                        "@reference-instance-id": "OB2BibRecID-947432937-88c731563c5f04fbffc45193782fb989-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "The somatic genomic landscape of glioblastoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0014",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84885074034",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "155",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "462",
                                    "@last": "477"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Brennan",
                                        "ce:indexed-name": "Brennan C.W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.G.",
                                        "@_fa": "true",
                                        "ce:surname": "Verhaak",
                                        "ce:indexed-name": "Verhaak R.G."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "McKenna",
                                        "ce:indexed-name": "McKenna A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Brennan CW, Verhaak RG, McKenna A, et al. The somatic genomic landscape of glioblastoma. Cell. 2013;155(2):462-477."
                    },
                    {
                        "ref-fulltext": "Cardona AF, Jaramillo-Velasquez D, Ruiz-Patino A, et al. Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation. J Neurooncol. 2021;154(3):353-364.",
                        "@reference-instance-id": "OB2BibRecID-947432937-5f17ad59e95a8337f7d0029298bcf89e-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0015",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85114404871",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "154",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "353",
                                    "@last": "364"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.F.",
                                        "@_fa": "true",
                                        "ce:surname": "Cardona",
                                        "ce:indexed-name": "Cardona A.F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Jaramillo-Velasquez",
                                        "ce:indexed-name": "Jaramillo-Velasquez D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ruiz-Patino",
                                        "ce:indexed-name": "Ruiz-Patino A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Neurooncol"
                        },
                        "ce:source-text": "Cardona AF, Jaramillo-Velasquez D, Ruiz-Patino A, et al. Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation. J Neurooncol. 2021;154(3):353-364."
                    },
                    {
                        "ref-fulltext": "Hein AL, Cathcart SJ, Cushman-Vokoun A, et al. EGFR exon 20 insertion in bithalamic and unithalamic glioma: a report of 2 cases and literature review. J Neuropathol Exp Neurol. 2022;81(11):943-946.",
                        "@reference-instance-id": "OB2BibRecID-947432937-91d48623d199be787d76bd29c7c4ede9-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "EGFR exon 20 insertion in bithalamic and unithalamic glioma: a report of 2 cases and literature review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0016",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85140415152",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "81",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "943",
                                    "@last": "946"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Hein",
                                        "ce:indexed-name": "Hein A.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Cathcart",
                                        "ce:indexed-name": "Cathcart S.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cushman-Vokoun",
                                        "ce:indexed-name": "Cushman-Vokoun A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Neuropathol Exp Neurol"
                        },
                        "ce:source-text": "Hein AL, Cathcart SJ, Cushman-Vokoun A, et al. EGFR exon 20 insertion in bithalamic and unithalamic glioma: a report of 2 cases and literature review. J Neuropathol Exp Neurol. 2022;81(11):943-946."
                    },
                    {
                        "ref-fulltext": "Chi AS, Batchelor TT, Dias-Santagata D, et al. Prospective, high-throughput molecular profiling of human gliomas. J Neurooncol. 2012;110(1):89-98.",
                        "@reference-instance-id": "OB2BibRecID-947432937-f11edbf65b72b88d525b1797290a03a9-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Prospective, high-throughput molecular profiling of human gliomas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0017",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84866402680",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "110",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "89",
                                    "@last": "98"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Chi",
                                        "ce:indexed-name": "Chi A.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Batchelor",
                                        "ce:indexed-name": "Batchelor T.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Dias-Santagata",
                                        "ce:indexed-name": "Dias-Santagata D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Neurooncol"
                        },
                        "ce:source-text": "Chi AS, Batchelor TT, Dias-Santagata D, et al. Prospective, high-throughput molecular profiling of human gliomas. J Neurooncol. 2012;110(1):89-98."
                    },
                    {
                        "ref-fulltext": "Cryan JB, Haidar S, Ramkissoon LA, et al. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget. 2014;5(18):8083-8092.",
                        "@reference-instance-id": "OB2BibRecID-947432937-cb17fa28a41597d80fd5f055bf3eb9b6-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0018",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84907998639",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "5",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "8083",
                                    "@last": "8092"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Cryan",
                                        "ce:indexed-name": "Cryan J.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Haidar",
                                        "ce:indexed-name": "Haidar S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ramkissoon",
                                        "ce:indexed-name": "Ramkissoon L.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Cryan JB, Haidar S, Ramkissoon LA, et al. Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas. Oncotarget. 2014;5(18):8083-8092."
                    },
                    {
                        "ref-fulltext": "Felsberg J, Hentschel B, Kaulich K, et al. Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified glioblastomas: prognostic role and comparison between primary and recurrent tumors. Clin Cancer Res. 2017;23(22):6846-6855.",
                        "@reference-instance-id": "OB2BibRecID-947432937-2ec907b86e7ca9ad7dbacea2dcf8ce56-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified glioblastomas: prognostic role and comparison between primary and recurrent tumors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0019",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85034831606",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "22"
                                },
                                "pagerange": {
                                    "@first": "6846",
                                    "@last": "6855"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Felsberg",
                                        "ce:indexed-name": "Felsberg J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Hentschel",
                                        "ce:indexed-name": "Hentschel B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kaulich",
                                        "ce:indexed-name": "Kaulich K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Felsberg J, Hentschel B, Kaulich K, et al. Epidermal growth factor receptor variant III (EGFRvIII) positivity in EGFR-amplified glioblastomas: prognostic role and comparison between primary and recurrent tumors. Clin Cancer Res. 2017;23(22):6846-6855."
                    },
                    {
                        "ref-fulltext": "Fukushima T, Favereaux A, Huang H, et al. Genetic alterations in primary glioblastomas in Japan. J Neuropathol Exp Neurol. 2006;65(1):12-18.",
                        "@reference-instance-id": "OB2BibRecID-947432937-301376e81d32c34e204cb94b7b94235a-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Genetic alterations in primary glioblastomas in Japan"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0020",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33644880865",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "65",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "12",
                                    "@last": "18"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Fukushima",
                                        "ce:indexed-name": "Fukushima T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Favereaux",
                                        "ce:indexed-name": "Favereaux A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Huang",
                                        "ce:indexed-name": "Huang H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Neuropathol Exp Neurol"
                        },
                        "ce:source-text": "Fukushima T, Favereaux A, Huang H, et al. Genetic alterations in primary glioblastomas in Japan. J Neuropathol Exp Neurol. 2006;65(1):12-18."
                    },
                    {
                        "ref-fulltext": "Lee JC, Vivanco I, Beroukhim R, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med. 2006;3(12):e485.",
                        "@reference-instance-id": "OB2BibRecID-947432937-65d985766da3328fdff69360989bb39e-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0021",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "33845926387",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {
                                "@volume": "3",
                                "@issue": "12"
                            }},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Vivanco",
                                        "ce:indexed-name": "Vivanco I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Beroukhim",
                                        "ce:indexed-name": "Beroukhim R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS Med"
                        },
                        "ce:source-text": "Lee JC, Vivanco I, Beroukhim R, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med. 2006;3(12):e485."
                    },
                    {
                        "ref-fulltext": "Lee JK, Wang J, Sa JK, et al. Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Nat Genet. 2017;49(4):594-599.",
                        "@reference-instance-id": "OB2BibRecID-947432937-23498eb64a11623a8c77c91b39abb11a-22",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Spatiotemporal genomic architecture informs precision oncology in glioblastoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0022",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85014515130",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "49",
                                    "@issue": "4"
                                },
                                "pagerange": {
                                    "@first": "594",
                                    "@last": "599"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Sa",
                                        "ce:indexed-name": "Sa J.K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Genet"
                        },
                        "ce:source-text": "Lee JK, Wang J, Sa JK, et al. Spatiotemporal genomic architecture informs precision oncology in glioblastoma. Nat Genet. 2017;49(4):594-599."
                    },
                    {
                        "ref-fulltext": "McNulty SN, Schwetye KE, Ferguson C, et al. BRAF mutations may identify a clinically distinct subset of glioblastoma. Sci Rep. 2021;11(1):19999.",
                        "@reference-instance-id": "OB2BibRecID-947432937-e8674997b14a7480511fc7d414d87749-23",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "BRAF mutations may identify a clinically distinct subset of glioblastoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0023",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85116780127",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "11",
                                    "@issue": "1"
                                },
                                "pagerange": {"@first": "19999"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.N.",
                                        "@_fa": "true",
                                        "ce:surname": "McNulty",
                                        "ce:indexed-name": "McNulty S.N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Schwetye",
                                        "ce:indexed-name": "Schwetye K.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferguson",
                                        "ce:indexed-name": "Ferguson C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci Rep"
                        },
                        "ce:source-text": "McNulty SN, Schwetye KE, Ferguson C, et al. BRAF mutations may identify a clinically distinct subset of glioblastoma. Sci Rep. 2021;11(1):19999."
                    },
                    {
                        "ref-fulltext": "Molenaar RJ, Verbaan D, Lamba S, et al. The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone. Neuro Oncol. 2014;16(9):1263-1273.",
                        "@reference-instance-id": "OB2BibRecID-947432937-cf3e07b634fe72990eb31be32e9bccff-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0024",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84906505215",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "16",
                                    "@issue": "9"
                                },
                                "pagerange": {
                                    "@first": "1263",
                                    "@last": "1273"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Molenaar",
                                        "ce:indexed-name": "Molenaar R.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Verbaan",
                                        "ce:indexed-name": "Verbaan D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lamba",
                                        "ce:indexed-name": "Lamba S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Neuro Oncol"
                        },
                        "ce:source-text": "Molenaar RJ, Verbaan D, Lamba S, et al. The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone. Neuro Oncol. 2014;16(9):1263-1273."
                    },
                    {
                        "ref-fulltext": "Nguyen SA, Stechishin OD, Luchman HA, et al. Novel MSH6 mutations in treatment-naive glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation. Clin Cancer Res. 2014;20(18):4894-4903.",
                        "@reference-instance-id": "OB2BibRecID-947432937-08ce5078ed40a085431d2279e97783b0-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Novel MSH6 mutations in treatment-naive glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0025",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84907426055",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "20",
                                    "@issue": "18"
                                },
                                "pagerange": {
                                    "@first": "4894",
                                    "@last": "4903"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Nguyen",
                                        "ce:indexed-name": "Nguyen S.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "O.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Stechishin",
                                        "ce:indexed-name": "Stechishin O.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Luchman",
                                        "ce:indexed-name": "Luchman H.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Nguyen SA, Stechishin OD, Luchman HA, et al. Novel MSH6 mutations in treatment-naive glioblastoma and anaplastic oligodendroglioma contribute to temozolomide resistance independently of MGMT promoter methylation. Clin Cancer Res. 2014;20(18):4894-4903."
                    },
                    {
                        "ref-fulltext": "Pain M, Wang H, Lee E, et al. Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma. Oncotarget. 2017;9(2):2603-2621.",
                        "@reference-instance-id": "OB2BibRecID-947432937-abd9b0634eea44acd1c91233bf5b4bb1-26",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0026",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040017536",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "9",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "2603",
                                    "@last": "2621"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Pain",
                                        "ce:indexed-name": "Pain M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Pain M, Wang H, Lee E, et al. Treatment-associated TP53 DNA-binding domain missense mutations in the pathogenesis of secondary gliosarcoma. Oncotarget. 2017;9(2):2603-2621."
                    },
                    {
                        "ref-fulltext": "Pal J, Patil V, Kumar A, Kaur K, Sarkar C, Somasundaram K. Loss-of-function mutations in calcitonin receptor (CALCR) identify highly aggressive glioblastoma with poor outcome. Clin Cancer Res. 2018;24(6):1448-1458.",
                        "@reference-instance-id": "OB2BibRecID-947432937-c5e80ac40ad4eabe5e3bbf951d283135-27",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Loss-of-function mutations in calcitonin receptor (CALCR) identify highly aggressive glioblastoma with poor outcome"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0027",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85047039281",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "24",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1448",
                                    "@last": "1458"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Pal",
                                    "ce:indexed-name": "Pal J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Patil",
                                    "ce:indexed-name": "Patil V."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kumar",
                                    "ce:indexed-name": "Kumar A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Kaur",
                                    "ce:indexed-name": "Kaur K."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Sarkar",
                                    "ce:indexed-name": "Sarkar C."
                                },
                                {
                                    "@seq": "6",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Somasundaram",
                                    "ce:indexed-name": "Somasundaram K."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Pal J, Patil V, Kumar A, Kaur K, Sarkar C, Somasundaram K. Loss-of-function mutations in calcitonin receptor (CALCR) identify highly aggressive glioblastoma with poor outcome. Clin Cancer Res. 2018;24(6):1448-1458."
                    },
                    {
                        "ref-fulltext": "Tang C, Guo J, Chen H, et al. Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy. Int J Clin Exp Pathol. 2015;8(5):5327-5335.",
                        "@reference-instance-id": "OB2BibRecID-947432937-fd94fc53baa6ab0384a6be6778c737fb-28",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0028",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84937840507",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "5327",
                                    "@last": "5335"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Tang",
                                        "ce:indexed-name": "Tang C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Guo",
                                        "ce:indexed-name": "Guo J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Clin Exp Pathol"
                        },
                        "ce:source-text": "Tang C, Guo J, Chen H, et al. Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy. Int J Clin Exp Pathol. 2015;8(5):5327-5335."
                    },
                    {
                        "ref-fulltext": "Zehir A, Benayed R, Shah RH, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23(6):703-713.",
                        "@reference-instance-id": "OB2BibRecID-947432937-ddd3d10fa9339b5a463186cc060476ff-29",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0029",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85020279899",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "23",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "703",
                                    "@last": "713"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Zehir",
                                        "ce:indexed-name": "Zehir A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Benayed",
                                        "ce:indexed-name": "Benayed R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah R.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Zehir A, Benayed R, Shah RH, et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med. 2017;23(6):703-713."
                    },
                    {
                        "ref-fulltext": "Franco-Hernandez C, Martinez-Glez V, Alonso ME, et al. Gene dosage and mutational analyses of EGFR in oligodendrogliomas. Int J Oncol. 2007;30(1):209-215.",
                        "@reference-instance-id": "OB2BibRecID-947432937-5e859ba90cb7d8eb4971b4fb0d6247af-30",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Gene dosage and mutational analyses of EGFR in oligodendrogliomas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0030",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "39049180584",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "30",
                                    "@issue": "1"
                                },
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "215"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Franco-Hernandez",
                                        "ce:indexed-name": "Franco-Hernandez C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V.",
                                        "@_fa": "true",
                                        "ce:surname": "Martinez-Glez",
                                        "ce:indexed-name": "Martinez-Glez V."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Alonso",
                                        "ce:indexed-name": "Alonso M.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Oncol"
                        },
                        "ce:source-text": "Franco-Hernandez C, Martinez-Glez V, Alonso ME, et al. Gene dosage and mutational analyses of EGFR in oligodendrogliomas. Int J Oncol. 2007;30(1):209-215."
                    },
                    {
                        "ref-fulltext": "Taher MM, Hassan AA, Saeed M, et al. Next generation DNA sequencing of atypical choroid plexus papilloma of brain: identification of novel mutations in a female patient by ion proton. Oncol Lett. 2019;18(5):5063-5076.",
                        "@reference-instance-id": "OB2BibRecID-947432937-db9ccc6b4981bf34d4ba99d6ce9c7b3e-31",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Next generation DNA sequencing of atypical choroid plexus papilloma of brain: identification of novel mutations in a female patient by ion proton"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0031",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85073745764",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "18",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "5063",
                                    "@last": "5076"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Taher",
                                        "ce:indexed-name": "Taher M.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Hassan",
                                        "ce:indexed-name": "Hassan A.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Saeed",
                                        "ce:indexed-name": "Saeed M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncol Lett"
                        },
                        "ce:source-text": "Taher MM, Hassan AA, Saeed M, et al. Next generation DNA sequencing of atypical choroid plexus papilloma of brain: identification of novel mutations in a female patient by ion proton. Oncol Lett. 2019;18(5):5063-5076."
                    },
                    {
                        "ref-fulltext": "Remon J, Steuer CE, Ramalingam SS, Felip E. Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients. Ann Oncol. 2018;29(suppl_1):i20-i27.",
                        "@reference-instance-id": "OB2BibRecID-947432937-0184c9063e868c1b9a2599e9bcb79a1e-32",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0032",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85042924397",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "i20",
                                    "@last": "i27"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Remon",
                                    "ce:indexed-name": "Remon J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Steuer",
                                    "ce:indexed-name": "Steuer C.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Ramalingam",
                                    "ce:indexed-name": "Ramalingam S.S."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Felip",
                                    "ce:indexed-name": "Felip E."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Remon J, Steuer CE, Ramalingam SS, Felip E. Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients. Ann Oncol. 2018;29(suppl_1):i20-i27."
                    },
                    {
                        "ref-fulltext": "Floc'h N, Martin MJ, Riess JW, et al. Antitumor activity of osimertinib, an irreversible mutant-selective EGFR tyrosine kinase inhibitor, in NSCLC harboring EGFR exon 20 insertions. Mol Cancer Ther. 2018;17(5):885-896.",
                        "@reference-instance-id": "OB2BibRecID-947432937-7cfb94df1a458e9c53413bc6fef1d4f0-33",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Antitumor activity of osimertinib, an irreversible mutant-selective EGFR tyrosine kinase inhibitor, in NSCLC harboring EGFR exon 20 insertions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0033",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85045577388",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "17",
                                    "@issue": "5"
                                },
                                "pagerange": {
                                    "@first": "885",
                                    "@last": "896"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Floc'h",
                                        "ce:indexed-name": "Floc'h N."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Martin",
                                        "ce:indexed-name": "Martin M.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Riess",
                                        "ce:indexed-name": "Riess J.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol Cancer Ther"
                        },
                        "ce:source-text": "Floc'h N, Martin MJ, Riess JW, et al. Antitumor activity of osimertinib, an irreversible mutant-selective EGFR tyrosine kinase inhibitor, in NSCLC harboring EGFR exon 20 insertions. Mol Cancer Ther. 2018;17(5):885-896."
                    },
                    {
                        "ref-fulltext": "Pan PC, Magge RS. Mechanisms of EGFR resistance in glioblastoma. Int J Mol Sci. 2020;21(22):8471.",
                        "@reference-instance-id": "OB2BibRecID-947432937-0aa6a465522e16b8cb5030b643ae7609-34",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Mechanisms of EGFR resistance in glioblastoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0034",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85095989524",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "21",
                                    "@issue": "22"
                                },
                                "pagerange": {"@first": "8471"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Pan",
                                    "ce:indexed-name": "Pan P.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Magge",
                                    "ce:indexed-name": "Magge R.S."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Mol Sci"
                        },
                        "ce:source-text": "Pan PC, Magge RS. Mechanisms of EGFR resistance in glioblastoma. Int J Mol Sci. 2020;21(22):8471."
                    },
                    {
                        "ref-fulltext": "Goss G, Tsai CM, Shepherd FA, et al. CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials. Ann Oncol. 2018;29(3):687-693.",
                        "@reference-instance-id": "OB2BibRecID-947432937-9a1a86ace8c40bfb79e521d094ecceb3-35",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0035",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85045927702",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "29",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "687",
                                    "@last": "693"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Goss",
                                        "ce:indexed-name": "Goss G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Tsai",
                                        "ce:indexed-name": "Tsai C.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Shepherd",
                                        "ce:indexed-name": "Shepherd F.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Goss G, Tsai CM, Shepherd FA, et al. CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials. Ann Oncol. 2018;29(3):687-693."
                    },
                    {
                        "ref-fulltext": "Zwierenga F, van Veggel B, Hendriks LEL, et al. High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: results from the phase 2 multicenter POSITION20 trial. Lung Cancer. 2022;170:133-140.",
                        "@reference-instance-id": "OB2BibRecID-947432937-a58a191382c3447fe6d277f9e0e755d7-36",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: results from the phase 2 multicenter POSITION20 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0036",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85132893972",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "170"},
                                "pagerange": {
                                    "@first": "133",
                                    "@last": "140"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Zwierenga",
                                        "ce:indexed-name": "Zwierenga F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "van Veggel",
                                        "ce:indexed-name": "van Veggel B."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.E.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Hendriks",
                                        "ce:indexed-name": "Hendriks L.E.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lung Cancer"
                        },
                        "ce:source-text": "Zwierenga F, van Veggel B, Hendriks LEL, et al. High dose osimertinib in patients with advanced stage EGFR exon 20 mutation-positive NSCLC: results from the phase 2 multicenter POSITION20 trial. Lung Cancer. 2022;170:133-140."
                    },
                    {
                        "ref-fulltext": "Yasuda H, Ichihara E, Sakakibara-Konishi J, et al. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. Lung Cancer. 2021;162:140-146.",
                        "@reference-instance-id": "OB2BibRecID-947432937-ea40b9b2aaef4de45c0aa453b49c3a1a-37",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0037",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85119376324",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "162"},
                                "pagerange": {
                                    "@first": "140",
                                    "@last": "146"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Yasuda",
                                        "ce:indexed-name": "Yasuda H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E.",
                                        "@_fa": "true",
                                        "ce:surname": "Ichihara",
                                        "ce:indexed-name": "Ichihara E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Sakakibara-Konishi",
                                        "ce:indexed-name": "Sakakibara-Konishi J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lung Cancer"
                        },
                        "ce:source-text": "Yasuda H, Ichihara E, Sakakibara-Konishi J, et al. A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer. Lung Cancer. 2021;162:140-146."
                    },
                    {
                        "ref-fulltext": "Kian W, Christopoulos P, Remilah AA, et al. Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer. Front Oncol. 2022;12:1010311.",
                        "@reference-instance-id": "OB2BibRecID-947432937-111c0c271804b8823ed5aa6b995959a2-38",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0038",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85140074734",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {"@first": "1010311"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kian",
                                        "ce:indexed-name": "Kian W."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Christopoulos",
                                        "ce:indexed-name": "Christopoulos P."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Remilah",
                                        "ce:indexed-name": "Remilah A.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Oncol"
                        },
                        "ce:source-text": "Kian W, Christopoulos P, Remilah AA, et al. Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer. Front Oncol. 2022;12:1010311."
                    },
                    {
                        "ref-fulltext": "Le X, Cornelissen R, Garassino M, et al. Poziotinib in non-small-cell lung cancer harboring HER2 exon 20 insertion mutations after prior therapies: ZENITH20-2 trial. J Clin Oncol. 2022;40(7):710-718.",
                        "@reference-instance-id": "OB2BibRecID-947432937-16119c12752cffe7eda7fcb5d4d312d7-39",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Poziotinib in non-small-cell lung cancer harboring HER2 exon 20 insertion mutations after prior therapies: ZENITH20-2 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0039",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85121320083",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "40",
                                    "@issue": "7"
                                },
                                "pagerange": {
                                    "@first": "710",
                                    "@last": "718"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "X.",
                                        "@_fa": "true",
                                        "ce:surname": "Le",
                                        "ce:indexed-name": "Le X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Cornelissen",
                                        "ce:indexed-name": "Cornelissen R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Garassino",
                                        "ce:indexed-name": "Garassino M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Le X, Cornelissen R, Garassino M, et al. Poziotinib in non-small-cell lung cancer harboring HER2 exon 20 insertion mutations after prior therapies: ZENITH20-2 trial. J Clin Oncol. 2022;40(7):710-718."
                    },
                    {
                        "ref-fulltext": "Mondal G, Lee JC, Ravindranathan A, et al. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol. 2020;139(6):1071-1088.",
                        "@reference-instance-id": "OB2BibRecID-947432937-e80e0281f64db9c249e3578b2b5472a6-40",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0040",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85083559982",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "139",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1071",
                                    "@last": "1088"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "G.",
                                        "@_fa": "true",
                                        "ce:surname": "Mondal",
                                        "ce:indexed-name": "Mondal G."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ravindranathan",
                                        "ce:indexed-name": "Ravindranathan A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Acta Neuropathol"
                        },
                        "ce:source-text": "Mondal G, Lee JC, Ravindranathan A, et al. Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition. Acta Neuropathol. 2020;139(6):1071-1088."
                    },
                    {
                        "ref-fulltext": "Makhlin I, Salinas RD, Zhang D, et al. Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma. CNS Oncol. 2019;8(3):CNS43.",
                        "@reference-instance-id": "OB2BibRecID-947432937-4fecffb836451643166c4af5f90a6588-41",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0041",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85084693617",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "3"
                                },
                                "pagerange": {"@first": "CNS43"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Makhlin",
                                        "ce:indexed-name": "Makhlin I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Salinas",
                                        "ce:indexed-name": "Salinas R.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "CNS Oncol"
                        },
                        "ce:source-text": "Makhlin I, Salinas RD, Zhang D, et al. Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma. CNS Oncol. 2019;8(3):CNS43."
                    },
                    {
                        "ref-fulltext": "Byeon S, Hong JY, Lee J, et al. Use of gefitinib in EGFR-amplified refractory solid tumors: An open-label, single-arm, single-center prospective pilot study. Target Oncol. 2020;15(2):185-192.",
                        "@reference-instance-id": "OB2BibRecID-947432937-936e9ac80b27d94a3d1c2d287428b1c9-42",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Use of gefitinib in EGFR-amplified refractory solid tumors: An open-label, single-arm, single-center prospective pilot study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0042",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85081039693",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "15",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "185",
                                    "@last": "192"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Byeon",
                                        "ce:indexed-name": "Byeon S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Hong",
                                        "ce:indexed-name": "Hong J.Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Target Oncol"
                        },
                        "ce:source-text": "Byeon S, Hong JY, Lee J, et al. Use of gefitinib in EGFR-amplified refractory solid tumors: An open-label, single-arm, single-center prospective pilot study. Target Oncol. 2020;15(2):185-192."
                    },
                    {
                        "ref-fulltext": "Sepulveda-Sanchez JM, Vaz MA, Balana C, et al. Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification. Neuro Oncol. 2017;19(11):1522-1531.",
                        "@reference-instance-id": "OB2BibRecID-947432937-24177a1dd65d85eb10f75106c2ea39b2-43",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0043",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85032445984",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "19",
                                    "@issue": "11"
                                },
                                "pagerange": {
                                    "@first": "1522",
                                    "@last": "1531"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Sepulveda-Sanchez",
                                        "ce:indexed-name": "Sepulveda-Sanchez J.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Vaz",
                                        "ce:indexed-name": "Vaz M.A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Balana",
                                        "ce:indexed-name": "Balana C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Neuro Oncol"
                        },
                        "ce:source-text": "Sepulveda-Sanchez JM, Vaz MA, Balana C, et al. Phase II trial of dacomitinib, a pan-human EGFR tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification. Neuro Oncol. 2017;19(11):1522-1531."
                    },
                    {
                        "ref-fulltext": "Gazdar AF. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene. 2009;28(Suppl 1):S24-S31.",
                        "@reference-instance-id": "OB2BibRecID-947432937-32b733dfb07c4359f44383e38b14f3d9-44",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0044",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "68949201629",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "S24",
                                    "@last": "S31"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.F.",
                                "@_fa": "true",
                                "ce:surname": "Gazdar",
                                "ce:indexed-name": "Gazdar A.F."
                            }]},
                            "ref-sourcetitle": "Oncogene"
                        },
                        "ce:source-text": "Gazdar AF. Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene. 2009;28(Suppl 1):S24-S31."
                    },
                    {
                        "ref-fulltext": "Hegi ME, Diserens AC, Bady P, et al. Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib\u2014a phase II trial. Mol Cancer Ther. 2011;10(6):1102-1112.",
                        "@reference-instance-id": "OB2BibRecID-947432937-c05bad7426f2ab5abc894bb08c8c0852-45",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib\u2014a phase II trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "gcc23143-cit-0045",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "79958757490",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "10",
                                    "@issue": "6"
                                },
                                "pagerange": {
                                    "@first": "1102",
                                    "@last": "1112"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Hegi",
                                        "ce:indexed-name": "Hegi M.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Diserens",
                                        "ce:indexed-name": "Diserens A.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Bady",
                                        "ce:indexed-name": "Bady P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Mol Cancer Ther"
                        },
                        "ce:source-text": "Hegi ME, Diserens AC, Bady P, et al. Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib\u2014a phase II trial. Mol Cancer Ther. 2011;10(6):1102-1112."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85152274374",
        "dc:description": "Glioblastoma (GBM) is a high-grade adult-type IDH-wildtype diffuse glioma, commonly harboring epidermal growth factor receptor (EGFR) amplification. Here, we describe a case of a 49-year-old man with a GBM harboring a TERT promoter mutation. Despite surgical and chemoradiation therapy, the tumor recurred. At that time, comprehensive genomic profiling by next-generation sequencing identified two rare mutations in EGFR: T790M and an exon 20 insertion. Based on these findings, the patient elected to undergo off-label therapy with osimertinib, a third-generation EGFR tyrosine kinase inhibitor that has shown promising results in non-small cell lung carcinoma, including metastatic to brain, with exactly the same EGFR mutations. Moreover, the drug has excellent central nervous system penetration. Even so, no clinical response was observed, and the patient succumbed to the disease. The lack of response may be related to the specific nature of the EGFR mutations, and/or other unfavorable tumor biology overriding any benefit from osimertinib.",
        "pubmed-id": "36994936",
        "prism:coverDate": "2023-07-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85152274374",
        "dc:creator": {"author": [{
            "ce:given-name": "Atthaporn",
            "preferred-name": {
                "ce:given-name": "Atthaporn",
                "ce:initials": "A.",
                "ce:surname": "Boongird",
                "ce:indexed-name": "Boongird A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Boongird",
            "@auid": "16041254300",
            "author-url": "https://api.elsevier.com/content/author/author_id/16041254300",
            "ce:indexed-name": "Boongird A."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85152274374"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85152274374&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85152274374&origin=inward"
            }
        ],
        "source-id": "22139",
        "citedby-count": "1",
        "prism:volume": "62",
        "subtype": "ar",
        "dc:title": "Glioblastoma with novel EGFR mutations (T790M and exon 20 insertion) yet unresponsive to osimertinib: A case report",
        "openaccess": "0",
        "prism:issn": "10982264 10452257",
        "publishercopyright": "Â© 2023 Wiley Periodicals LLC.",
        "prism:issueIdentifier": "7",
        "subtypeDescription": "Article",
        "prism:publicationName": "Genes Chromosomes and Cancer",
        "prism:pageRange": "423-429",
        "prism:endingPage": "429",
        "openaccessFlag": "false",
        "prism:doi": "10.1002/gcc.23143",
        "prism:startingPage": "423",
        "dc:identifier": "SCOPUS_ID:85152274374",
        "dc:publisher": "John Wiley and Sons Inc"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "ErbB Receptors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Glioblastoma",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Glioma",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lung Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Mutation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Neoplasm Recurrence, Local",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Protein Kinase Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "comprehensive genomic profiling"
        },
        {
            "@_fa": "true",
            "$": "EGFR"
        },
        {
            "@_fa": "true",
            "$": "exon 20 insertion"
        },
        {
            "@_fa": "true",
            "$": "glioblastoma"
        },
        {
            "@_fa": "true",
            "$": "next-generation sequencing"
        },
        {
            "@_fa": "true",
            "$": "osimertinib"
        },
        {
            "@_fa": "true",
            "$": "T790M"
        },
        {
            "@_fa": "true",
            "$": "tyrosine kinase inhibitor"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Genetics",
            "@code": "1311",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Atthaporn",
            "preferred-name": {
                "ce:given-name": "Atthaporn",
                "ce:initials": "A.",
                "ce:surname": "Boongird",
                "ce:indexed-name": "Boongird A."
            },
            "@seq": "1",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Boongird",
            "@auid": "16041254300",
            "author-url": "https://api.elsevier.com/content/author/author_id/16041254300",
            "ce:indexed-name": "Boongird A."
        },
        {
            "ce:given-name": "Nopphon",
            "preferred-name": {
                "ce:given-name": "Nopphon",
                "ce:initials": "N.",
                "ce:surname": "Lekcharoensombat",
                "ce:indexed-name": "Lekcharoensombat N."
            },
            "@seq": "2",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Lekcharoensombat",
            "@auid": "58180412400",
            "author-url": "https://api.elsevier.com/content/author/author_id/58180412400",
            "ce:indexed-name": "Lekcharoensombat N."
        },
        {
            "ce:given-name": "Artit",
            "preferred-name": {
                "ce:given-name": "Artit",
                "ce:initials": "A.",
                "ce:surname": "Jinawath",
                "ce:indexed-name": "Jinawath A."
            },
            "@seq": "3",
            "ce:initials": "A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Jinawath",
            "@auid": "8623186500",
            "author-url": "https://api.elsevier.com/content/author/author_id/8623186500",
            "ce:indexed-name": "Jinawath A."
        },
        {
            "ce:given-name": "Talent",
            "preferred-name": {
                "ce:given-name": "Talent",
                "ce:initials": "T.",
                "ce:surname": "Theparee",
                "ce:indexed-name": "Theparee T."
            },
            "@seq": "4",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Theparee",
            "@auid": "56545822500",
            "author-url": "https://api.elsevier.com/content/author/author_id/56545822500",
            "ce:indexed-name": "Theparee T."
        },
        {
            "ce:given-name": "Nutchawan",
            "preferred-name": {
                "ce:given-name": "Nutchawan",
                "ce:initials": "N.",
                "ce:surname": "Jittapiromsak",
                "ce:indexed-name": "Jittapiromsak N."
            },
            "@seq": "5",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Jittapiromsak",
            "@auid": "57190178086",
            "author-url": "https://api.elsevier.com/content/author/author_id/57190178086",
            "ce:indexed-name": "Jittapiromsak N."
        },
        {
            "ce:given-name": "Shanop",
            "preferred-name": {
                "ce:given-name": "Shanop",
                "ce:initials": "S.",
                "ce:surname": "Shuangshoti",
                "ce:indexed-name": "Shuangshoti S."
            },
            "@seq": "6",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                }
            ],
            "ce:surname": "Shuangshoti",
            "@auid": "55063064300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55063064300",
            "ce:indexed-name": "Shuangshoti S."
        },
        {
            "ce:given-name": "Paul Scott",
            "preferred-name": {
                "ce:given-name": "Paul Scott",
                "ce:initials": "P.S.",
                "ce:surname": "Thorner",
                "ce:indexed-name": "Thorner P.S."
            },
            "@seq": "7",
            "ce:initials": "P.S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60002620",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
                },
                {
                    "@id": "60016849",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849"
                }
            ],
            "ce:surname": "Thorner",
            "@auid": "7005811935",
            "author-url": "https://api.elsevier.com/content/author/author_id/7005811935",
            "ce:indexed-name": "Thorner P.S."
        },
        {
            "ce:given-name": "Chinachote",
            "preferred-name": {
                "ce:given-name": "Chinachote",
                "ce:initials": "C.",
                "ce:surname": "Teerapakpinyo",
                "ce:indexed-name": "Teerapakpinyo C."
            },
            "@seq": "8",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002620",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620"
            },
            "ce:surname": "Teerapakpinyo",
            "@auid": "56653456600",
            "author-url": "https://api.elsevier.com/content/author/author_id/56653456600",
            "ce:indexed-name": "Teerapakpinyo C."
        }
    ]}
}}